Skip to main content
SpringerLink
Log in

Evidence-Based Policy Recommendations on Screening and Prevention

  • Chapter
Cancer Precursors

  • 223 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kramer BS. NCI State-of-the-art statements on cancer screening. In: Greenwald P, Kramer BS, Weed DL (eds) Cancer prevention and control. New York: Marcel Dekker, 1995, p. 721.

    Google Scholar 

  2. Screening for Cancer (PDQ) Screening/Detection—Health Professionals. Available at URL: http://cancernet.nci.nih.gov/pdq/pdq_screening.shtml.

  3. Baines CJ, Miller AB. Mammography versus clinical examination of the breasts. J Natl Cancer Inst Monogr 1997; 22:125–9.

    PubMed  Google Scholar 

  4. La Vecchia C, Franceschi S, Decarli A, et al. “Pap” smear and the risk of cervical neoplasia quantitative estimates from a case-control study. Lancet 191984; 2:779–82

    PubMed  Google Scholar 

  5. Herrero R, Brinton LA, Reeves WC, et al. Screening for cervical cancer in Latin America: a case-control study. Int J Epidemiol 1992; 21:1050–6.

    PubMed  CAS  Google Scholar 

  6. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987; 1:1247–9.

    PubMed  CAS  Google Scholar 

  7. Benedet JL, Anderson MB, Matisic JP. A comprehensive program for cervical cancer detection and management. Am J Obstet Gynecol 1992; 166:1254–9.

    PubMed  CAS  Google Scholar 

  8. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1467–71.

    Article  PubMed  CAS  Google Scholar 

  9. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecaloccult-blood screening for colorectal cancer. Lancet 1996; 348:1472–7.

    Article  PubMed  CAS  Google Scholar 

  10. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85:1311–18.

    PubMed  CAS  Google Scholar 

  11. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91:434–7.

    Article  PubMed  CAS  Google Scholar 

  12. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112:594–642.

    Article  PubMed  CAS  Google Scholar 

  13. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy: the National Polyp Study Workgroup. N Engl J Med 1993; 329:1977–81.

    Article  PubMed  CAS  Google Scholar 

  14. Rembacken BJ, Fujii T, Cairns A, et al. Flat and depressed colonic neoplasms: a prospective study of 1,000 colonoscopies in the UK. Lancet 2000; 355:1211–14.

    Article  PubMed  CAS  Google Scholar 

  15. Gohagan JK, Prorok PC, Kramer BS, et al. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening of the National Cancer Institute. J Urol 1994; 152:1905–9.

    PubMed  CAS  Google Scholar 

  16. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99–105.

    Article  PubMed  CAS  Google Scholar 

  17. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132:810–19.

    PubMed  CAS  Google Scholar 

  18. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 2000; 83:561–5.

    Article  PubMed  CAS  Google Scholar 

  19. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000; 92:1308–16.

    Article  PubMed  CAS  Google Scholar 

  20. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed. Washington, DC: U.S. Department of Health and Human Services, 1996.

    Google Scholar 

  21. Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa: Health Canada, 1994.

    Google Scholar 

  22. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40–49, January 21–23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst 1997; 89:1015–26.

    Google Scholar 

  23. Chalmers I. The Cochrane Collaboration: preparing, maintaining and disseminating systematic reviews of the effects of health care. Ann NY Acad Sci 1993; 703:156–63.

    PubMed  CAS  Google Scholar 

  24. Abstracts of Cochrane Reviews. The Cochrane Library Issue 4, 2000. Available at URL: http://hiru.mcmaster.ca/cochrane/cochrane/revabstr/mainindex.htm or URL: http://www.updatesoftware.com/cochrane/cochrane-frame.html.

  25. Towler BP, Irwig L, Glasziou P, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software; 2000.

    Google Scholar 

  26. Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software; 2000.

    Google Scholar 

  27. Martin-Hirsch P, Jarvis G, Kitchener H, et al. Collection devices for obtaining cervical cytology samples (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software; 2000.

    Google Scholar 

  28. McCrory DC, Matchar DB, Bastian L, et al. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment No. 5. AHCPR Publication No. 99-E010. Agency for Health Care Policy and Research. Rockville, MD: U.S. Department of Health and Human Services; 1999.

    Google Scholar 

  29. Agency for Health Care Policy and Research. Colorectal Cancer Screening. Technical Review 1. AHCPR Publication No. 98-0033. Rockville, MD: U.S. Department of Health and Human Services; 1998.

    Google Scholar 

  30. Noorani HZ, Arratoon C, Hall A. Assessment of techniques for cervical cancer screening. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 1997.

    Google Scholar 

  31. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999; 3:1–199.

    Google Scholar 

  32. Payne N, Chilcott J, McGoogan E. Liquid-based cytology in cervical screening: a rapid and systematic review. Health Technol Assess 2000; 4:1–73.

    PubMed  CAS  Google Scholar 

  33. Hubbard SM, Shields VT, Thurn AL. Information Systems in Oncology. In: Devita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th ed. Philadelphia: Lippincott-Raven, 1997, pp. 2983–91.

    Google Scholar 

  34. National Cancer Institute. CancerNet PDQ Cancer Information Summaries: Prevention. Available at URL: http://cancernet.nci.nih.gov/pdq/pdq_prevention.shtml.

  35. Gail MH, Costantino JP, Bryant J, et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999; 91:1829–46.

    Article  PubMed  CAS  Google Scholar 

  36. Sandler RS. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer. Cancer Principles Pract Oncol Updates 1997; 11:1–14.

    Google Scholar 

  37. The Writing Group for the PEPI trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Am Med Assoc 1996; 275:370–5.

    Google Scholar 

  38. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: the effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029–35.

    Google Scholar 

  39. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150–5.

    Article  PubMed  CAS  Google Scholar 

  40. Cochrane Tobacco Addiction Group. Abstracts of Cochrane Reviews. The Cochrane Library, Issue 4, 2000. Available at URL: http://www.update-software.com/abstracts/g160index.htm.

  41. Cochrane Gynaecological Cancer Group. Abstracts of Cochrane Reviews. The Cochrane Library, Issue 4, 2000. URL: www.updatesoftware.com/abstracts/ab001035.htm.

    Google Scholar 

  42. Franco EL. Epidemiology in the study of cancer. In: Bertino JR (ed.) Encyclopedia of Cancer, Vol. 1. San Diego: Academic Press, 1997, pp. 621–641.

    Google Scholar 

  43. Taubes G. NCI reverses one expert panel, sides with another. Science 1997; 276:27–8.

    PubMed  CAS  Google Scholar 

  44. Fink DJ. Chapter 12: Cancer detection: The cancer-related checkup guidelines. In: Holleb AI, Fink DJ, Murphy GP (eds) American Cancer Society textbook of clinical oncology. Atlanta American Cancer Society, 1991, pp. 153–76 (website updated guidelines available at URL: www2.cancer.org/SiteSearch/www3/SiteCenter.cfm?scDoc=41255).

    Google Scholar 

Download references

Authors
  1. Eduardo L. Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas E. Rohan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Oncology and Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  2. Division of Cancer Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  3. Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA

    Thomas E. Rohan MB, BS, PhD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Franco, E.L., Rohan, T.E. (2002). Evidence-Based Policy Recommendations on Screening and Prevention. In: Franco, E.L., Rohan, T.E. (eds) Cancer Precursors. Springer, New York, NY. https://doi.org/10.1007/0-387-21605-7_25

Download citation

  • DOI: https://doi.org/10.1007/0-387-21605-7_25

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95188-1

  • Online ISBN: 978-0-387-21605-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation